In our study, the upregulation of A20 in cancer cells promoted the growth of CRC via reducing the cell surface expression of CRT protein and facilitating tumor immune evasion in a STC1-CRT–dependent manner. This evidence concerns the gene CALR and colorectal carcinoma.